News Type: Research

Research projects from Sri Sarma and Michael Beer are featured in the Spring 2024 JHU Engineering's Magazine, in an article titled "Delivering on the Promise of Personalized Medicine." 

An undergraduate biomedical engineering design project yields a non-invasive method to measure life-threatening intracranial pressure.

The study offers insight into how the brain’s auditory cortex processes sound-related learning, advancing our understanding of how we process acoustic information.

In a breakthrough for guiding the treatment of atrial fibrillation (AF), the most common form of heart arrhythmia affecting millions, Johns Hopkins researchers have for the first time developed digital twins of patients’ hearts that allow physicians to more precisely identify optimal targets for ablation — a procedure during which small patches of tissue causing the faulty rhythm are burned away.

Johns Hopkins scientists have developed an artificial lymph node, which is implanted under the skin and designed to act like a learning hub and stimulator to teach immune system T-cells to recognize and kill cancer cells.

Shoebox-sized device promises earlier esophageal cancer detection in low-resource areas

Hopkins researchers develop a "one-stop shop” capsule for diagnosing and treating Barrett's esophagus, a condition known to be a precursor to esophageal cancer.

The new JHU Biotechnology Cooperation Center will be a hub for joint R&D collaboration with Korea in pharmaceuticals, medical devices, biomaterials, biomanufacturing, and AI/digital healthcare.

In a new IEEE paper, an alliance of 50 experts from 34 elite universities— including Johns Hopkins —reveal five research areas where the field of biomedical engineering has the potential to achieve tremendous impact on the field of medicine.

Johns Hopkins engineers develop a new computational method to precisely align spatial transcriptomics data across samples, resolutions, and technologies, enabling researchers to learn more about the underlying biology of cells.

Johns Hopkins researchers created RoboDrop: a robotic platform capable of rapidly screening multiple combinations of antibiotics simultaneously to find the most potent mixtures and provide a tool for understanding and navigating drug interactions.

Stouffer talks about her group’s work on understanding how the amygdala relates to Alzheimer’s disease progression and why it is a promising frontier for Alzheimer’s research and treatment.

Research from Johns Hopkins and University of Cambridge has been named one of National Geographic’s seven medical breakthroughs of 2023....

A Johns Hopkins University research team has created a dataset of simulated colonoscopy videos, called C3VD, that can help researchers evaluate how their computer vision models will perform in real-world scenarios.

Hopkins researchers develop new AI algorithm that can reconstruct brain images to identify potential biomarkers of neurodegenerative diseases.

The National Institutes of Health’s All of Us Research Program and 10 partner institutes, centers, and offices have funded 26...

A brain-computer interface (BCI) surgically implanted on the brain of an ALS (amyotrophic lateral sclerosis) patient has shown success in translating brain signals into computer commands.

The model's results correlated 85% with those calculated by a musculoskeletal pathologist.

Phillip, an assistant professor in the Department of Biomedical Engineering, has received a Junior Faculty award from the American Federation for Aging Research—Glenn Foundation to identify and classify subtypes of senescent cells.

The BRAIN CONNECTS program supports 11 projects that aim to develop technologies to comprehensively map neural connections in both humans and laboratory animals.

Funding from the Advanced Research Projects Agency for Health (ARPA-H) will fast-track the development of new cancer implant technology.

Breakthrough research from Jamie Spangler, an assistant professor of chemical and biomolecular engineering and biomedical engineering, has potential implications for treatment of injuries.

Deep-learning technology developed by Johns Hopkins researchers could help scientists overcome a major hurdle to developing personalized immunotherapies and vaccines.

New machine learning model could enable the development of therapies for cancer or other genomic diseases by activating genes on demand.

For a team of Johns Hopkins scientists, the acceleration of aging in space provides a unique opportunity to better comprehend the condition that remains the leading cause of death in America: heart disease.

Scientists have developed a tool called Geno-DT to create a digital replica of an individual's heart, which could inform the diagnosis and treatment of cardiovascular diseases.

A Johns Hopkins Medicine team suggests that microparticle-delivered therapy may be the first step toward stopping MS and other autoimmune diseases.

Researchers' work may help to predict and prevent the immune response that leads to fibrosis.

Tests in mice with melanoma and colon cancer show tiny particle creates an “army” of immune cells that carry vaccine’s instructions, researchers say.

The Leducq-funded project aims to find new therapies for heart disease by studying the effects of stimulating nerves.